WO2022175815 - METHODS OF PROTECTING RNA
National phase entry:
Publication Number
WO/2022/175815
Publication Date
25.08.2022
International Application No.
PCT/IB2022/051339
International Filing Date
15.02.2022
Title **
[English]
METHODS OF PROTECTING RNA
[French]
PROCÉDÉS DE PROTECTION DE L'ARN
Applicants **
PFIZER INC.
66 Hudson Boulevard East
New York, New York 10001-2192, US
Inventors
BELLENGER, Justin Leigh
c/o Pfizer Inc.
445 Eastern Point Road, Building 98
Groton, Connecticut 06340, US
CHE, Ye
c/o Pfizer Inc.
445 Eastern Point Road, Building 98
Groton, Connecticut 06340, US
GARCIA, Miguel Angel
c/o Pfizer Inc.
401 N. Middletown Road
Pearl River, New York 10965, US
HU, Lei
c/o Pfizer Inc.
401 N. Middletown Road
Pearl River, New York 10965, US
NOE, Mark Carl
c/o Pfizer Inc.
445 Eastern Point Road, Building 98
Groton, Connecticut 06340, US
SHI, Shuai
c/o Pfizer Inc.
401 N. Middletown Road
Pearl River, New York 10965, US
Priority Data
63/151,165
19.02.2021
US
63/261,437
21.09.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2259 | |
| EPO | Filing, Examination | 7974 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 3610 |
Total: 15041 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure provides methods of protecting ribonucleic acid (RNA) from degradation under certain conditions by contacting the RNA with an amino acid. The present disclosure also provides compositions comprising such amino acid(s) and RNA.[French]
La présente divulgation concerne des procédés de protection d'acide ribonucléique (ARN) contre la dégradation dans certaines conditions par mise en contact de l'ARN avec un acide aminé. La présente divulgation concerne également des compositions comprenant un tel acide aminé ou de tels acides aminés et un tel ARN.